September 18, 2018 Bio/Pharma/CRO Lab Top-10

MilliporeSigma Makes Major Investment in New Singapore Laboratory

Burlington, Massachusetts, September 18, 2018 – MilliporeSigma today announced the opening of a new 3,800-square-meter laboratory in Singapore. 18 SEP 2018 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA First GMP BioReliance® biosafety testing lab in Asia Pacific offering critical testing services to bring life-changing therapies to market Extensive range of upstream and downstream bioprocessing solutions through M Lab™... Read more

September 18, 2018 Bio/Pharma/CRO Clinical Research/Diagn. PR/Corporate

Reminder: Invitation to Roche's Virtual Pipeline Event: Key data for Roche's lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer

Basel, 18 September 2018 Reminder: Invitation to Roche’s Virtual Pipeline Event: Key data for Roche’s lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer Agenda Roche lung cancer portfolio key data IMpower133: Primary PFS, OS, and Safety in a Ph1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in... Read more

September 17, 2018 Bio/Pharma/CRO Informatics & Software M&A, Partnerships

Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research

NEW YORK; Sept. 17, 2018 – Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development. The new research platform,... Read more

September 17, 2018 Bio/Pharma/CRO Lab Top-10 Product Launch

New Validated Analytical Workflow for Complex Quantitation of Veterinary Drugs

Thermo Scientific VetDrugs Explorer Collection provides LC-MS/MS-based solution for multi-class veterinary drug residues in sample matrices SAN JOSE, Calif., Sept. 17, 2018 /PRNewswire/ — Food scientists can now take advantage of a newly-launched, start-to-finish solution that offers robust, reliable and sensitive analysis of multi-residue veterinary drugs in complex animal-derived sample matrices, helping identify animal and dairy... Read more

September 14, 2018 Bio/Pharma/CRO Life Science Tools M&A, Partnerships

Horizon Discovery Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform

Location: Cambridge, UK 14/09/2018 AstraZeneca joins Horizon’s Genomics Discovery Initiative CRISPR knockout and activation libraries are a key toolset in early research crRNA libraries are an efficient and convenient platform for gain- and loss-of-function studies Cambridge, UK, 14 September 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene... Read more

September 13, 2018 Bio/Pharma/CRO

Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the tenth year running

Basel, 13 September 2018 Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the tenth year running Sustainability is an integral part of Roche’s business strategy The company performed particularly well in Marketing Practices, Environmental and Social Reporting and Health Outcome Contribution For the tenth consecutive year, Roche (SIX: RO,... Read more

September 6, 2018 Bio/Pharma/CRO

Roche Provides Update on Supplemental Biologics License Application (sBLA) for TECENTRIQ in First-line Metastatic Non-Squamous NSCLC

Basel, 06 September 2018 Roche Provides Update on Supplemental Biologics License Application (sBLA) for TECENTRIQ in First-line Metastatic Non-Squamous NSCLC Roche (SIX: RO, ROG; OTCQX: RHHBY). On September 05 2018, Roche was notified by the U.S. Food and Drug Administration (FDA) that the review period for the supplemental Biologics License Application (sBLA) for TECENTRIQ® (atezolizumab)... Read more

September 6, 2018 Bio/Pharma/CRO

Roche to present new data from its extensive lung cancer programme at the 2018 World Conference on Lung Cancer (WCLC)

Basel, 06 September 2018 Roche to present new data from its extensive lung cancer programme at the 2018 World Conference on Lung Cancer (WCLC) New and updated pivotal data from the TECENTRIQ lung programme, including overall survival (OS) and progression-free survival (PFS) results from Phase III IMpower133 study in extensive-stage small cell lung cancer New... Read more

September 4, 2018 Bio/Pharma/CRO M&A, Partnerships

Pall Corporation and Celltheon Form Strategic Partnership for Biotherapeutics Development and Manufacturing With Celltheon Smart™ Expression Platform

PORT WASHINGTON, NY – September 4, 2018: Pall Corporation, a global leader in filtration, separation and purification, has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company. This partnership aligns Pall Biotech equipment and consumables with the Celltheon SMART™ Expression Platform to deliver integrated manufacturing solutions for customers developing... Read more